189 related articles for article (PubMed ID: 11529279)
21. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
Zietkowski Z; Skiepko R; Tomasiak-Lozowska MM; Lenczewska D; Bodzenta-Lukaszyk A
Int Arch Allergy Immunol; 2011; 154(1):25-32. PubMed ID: 20664274
[TBL] [Abstract][Full Text] [Related]
22. [Omalizumab in severe asthma--case report].
Gawlewicz-Mroczka A; Nizankowska-Mogilnicka E
Pol Arch Med Wewn; 2006 Aug; 116(2):766-70. PubMed ID: 17424922
[TBL] [Abstract][Full Text] [Related]
23. Anti-IgE treatment: an update.
Babu KS; Arshad SH; Holgate ST
Allergy; 2001 Dec; 56(12):1121-8. PubMed ID: 11736740
[No Abstract] [Full Text] [Related]
24. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
Holgate S; Bousquet J; Wenzel S; Fox H; Liu J; Castellsague J
Curr Med Res Opin; 2001; 17(4):233-40. PubMed ID: 11922396
[TBL] [Abstract][Full Text] [Related]
25. Vaccines targeting IgE in the treatment of asthma and allergy.
Peng Z
Hum Vaccin; 2009 May; 5(5):302-9. PubMed ID: 19221515
[TBL] [Abstract][Full Text] [Related]
26. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
Leuenberger P; Sauty A; Rochat T
Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
[TBL] [Abstract][Full Text] [Related]
27. Xolair in asthma therapy: an overview.
Di Domenico M; Bisogno A; Polverino M; De Rosa C; Ricci V; Capasso A
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):2-12. PubMed ID: 21184647
[TBL] [Abstract][Full Text] [Related]
28. Anti-IgE for chronic asthma in adults and children.
Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
[TBL] [Abstract][Full Text] [Related]
29. Omalizumab: a novel monoclonal antibody for treatment of allergic disease.
Piascik P
J Am Pharm Assoc (Wash); 2002; 42(2):356, 358. PubMed ID: 11926671
[No Abstract] [Full Text] [Related]
30. Summaries for patients. Omalizumab therapy for patients with severe asthma.
Ann Intern Med; 2011 May; 154(9):I28. PubMed ID: 21536934
[No Abstract] [Full Text] [Related]
31. Effect of omalizumab treatment in a baker with occupational asthma.
Pérez Pimiento A; Bueso Fernández A; García Loria J; Rodríguez Cabreros MI; Mosquera MR; García Cubero A
J Investig Allergol Clin Immunol; 2008; 18(6):490-1. PubMed ID: 19123449
[No Abstract] [Full Text] [Related]
32. Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease.
Aksu K; Kurt E
Allergol Immunopathol (Madr); 2013; 41(3):208-10. PubMed ID: 22763305
[No Abstract] [Full Text] [Related]
33. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.
Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H
Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
[TBL] [Abstract][Full Text] [Related]
35. Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.
Kulus M; Hébert J; Garcia E; Fowler Taylor A; Fernandez Vidaurre C; Blogg M
Curr Med Res Opin; 2010 Jun; 26(6):1285-93. PubMed ID: 20377320
[TBL] [Abstract][Full Text] [Related]
36. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
[TBL] [Abstract][Full Text] [Related]
37. The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.
Holgate S; Buhl R; Bousquet J; Smith N; Panahloo Z; Jimenez P
Respir Med; 2009 Aug; 103(8):1098-113. PubMed ID: 19362459
[TBL] [Abstract][Full Text] [Related]
38. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
Michils A; Sternon J
J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
[TBL] [Abstract][Full Text] [Related]
39. Omalizumab and other new drug therapies occupy a small space in asthma disease management.
Curtiss FR
J Manag Care Pharm; 2009 Apr; 15(3):289-93. PubMed ID: 19326961
[No Abstract] [Full Text] [Related]
40. [Anti-IgE therapy in persistent allergic asthma].
Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
